Market Update Economic Events Directors Deals Commodities Prices News Market Movers

Silence Therapeutics appoints Giles Campion as chief medical officer

Tuesday, 16th April 2019
Silence Therapeutics said it had appointed Giles Campion as its new head of R&D and chief medical officer.

Campion had previously served as chief medical officer at Prosensa and had also held senior R&D roles at Novartis.

'He has an outstanding track record of leading scientific development and advancing oligonucleotide-based medicines and is therefore ideally qualified to accelerate the development of our current and future pipeline,' chief executive David Horn Solomon said.

The appointment would take effect on 1 June.

Story provided by

Related Shares: Silence Ther.

Share Search
Share Search Share Search

Visit the Share Search.
Share Search

Share News
Share News will do their best to ensure the quality of the information displayed on this site, but all information is provided as-is, free of charge. We cannot be held responsible for any loss, material or otherwise, due to incorrect information found here. UK data supplied by NBTrader and Digital Look. Share Prices are at least 15 minutes delayed.